Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Dose_dense Capecitabine Schedule in colorectal cancers
Dose_dense Capecitabine schedule[7 days on_7days off] in colorectal cancer in comparison with standerd regimen
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm A :will receive capecitabine dose dense 1750 mg /m2 7days on treatment and 7 days off | Active Comparator |
| |
| Arm B will receive capecitabine standard dose 1000mg/m2 2weeks on and 1 week off | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Arm A:Dose_dense Capecitabine in Colorectal cancer | Drug | Appling dose _dense Capecitabine 1750mg/m2 for one week then one week off Cycle repeated every 2 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| 1_Quality of life assessed through EORTC_QLQ_CR29 questionaire | 2 years |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sohag university hospital | Sohag | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Dose_dense capecitabine schedule [7 days on _7 days off ] Compared to standerd regimen
Not provided
Not provided
Not provided
Not provided
| Arm B : standard dose Capecitabine | Drug | Pateints will receive capecitabine 1000 mg/m2 for 2 weeks then one week off |
|
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069287 | Capecitabine |
| ID | Term |
|---|---|
| D003841 | Deoxycytidine |
| D003562 | Cytidine |
| D011741 | Pyrimidine Nucleosides |
| D011743 | Pyrimidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D005472 | Fluorouracil |
| D014498 | Uracil |
| D011744 | Pyrimidinones |
| D003853 | Deoxyribonucleosides |
| D009705 | Nucleosides |
| D009706 | Nucleic Acids, Nucleotides, and Nucleosides |
Not provided
Not provided